期刊
JOURNAL OF IMMUNOLOGY
卷 186, 期 12, 页码 6657-6660出版社
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1100603
关键词
-
类别
资金
- National Institutes of Health [T32 AI07051, AI08382]
- MRC [G0501670] Funding Source: UKRI
- Medical Research Council [G0501670] Funding Source: researchfish
Cerebral malaria is the most severe complication of Plasmodium falciparum infection and accounts for a large number of malaria fatalities worldwide. Recent studies demonstrated that C5(-/-) mice are resistant to experimental cerebral malaria (ECM) and suggested that protection was due to loss of C5a-induced inflammation. Surprisingly, we observed that C5aR(-/-) mice were fully susceptible to disease, indicating that C5a is not required for ECM. C3aR(-/-) and C3aR(-/-) X C5aR(-/-) mice were equally susceptible to ECM as were wild-type mice, indicating that neither complement anaphylatoxin receptor is critical for ECM development. In contrast, C9 deposition in the brains of mice with ECM suggested an important role for the terminal complement pathway. Treatment with anti-C9 Ab significantly increased survival time and reduced mortality in ECM. Our data indicate that protection from ECM in C5(-/-) mice is mediated through inhibition of membrane attack complex formation and not through C5a-induced inflammation. The Journal of Immunology, 2011, 186: 6657-6660.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据